Oral Weight Loss Drug Orforglipron Shows Promise in Head-to-Head Trial Against Semaglutide
A new oral weight loss medication is showing promising results in direct comparison with existing treatments. The once-daily pill, orforglipron, outperformed oral semaglutide—the non-injectable form of drugs like Ozempic and Wegovy—in a major clinical trial.
The trial results showed that orforglipron delivered better outcomes for both weight loss